Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | CES2 | O00748 | 4/20 | 0.63 |
| ▸ | CES1 | P23141 | 4/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29030206 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL12503965 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL11683635 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL11335702 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL10866088 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL23735964 | 0.97 | KMT2A (0.68) | KMT2AMAPTCES2CES1AKR1B1 | |
| SCHEMBL9628746 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL8193983 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL9628655 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL10744476 | 0.97 | KMT2A (0.76) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9194471-A | — | — | None | — | — | JP | disclosed |
| EP-4006063-A1 | METHOD FOR PRODUCING FLUOROPOLYMER, POLYTETRAFLUOROETHYLENE COMPOSITION, AND POLYTETRAFLUOROETHYLENE POWDER | Daikin Industries, Ltd. (JP) | 2022-06-01 | — | — | EP | disclosed |
| EP-3922435-A1 | COMPOSITION, STRETCHED BODY AND METHOD OF MANUFACTURING THEREOF | DAIKIN INDUSTRIES, LTD. (JP) | 2021-12-15 | — | — | EP | disclosed |
| EP-3919527-A1 | METHOD FOR PRODUCING POLYTETRAFLUOROETHYLENE | DAIKIN INDUSTRIES, LTD. (JP) | 2021-12-08 | — | — | EP | disclosed |
| EP-3862324-A1 | METHOD FOR REMOVING FLUORINE-CONTAINING COMPOUND FROM WASTE WATER | DAIKIN INDUSTRIES, LTD. (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-3862368-A1 | POLYTETRAFLUOROETHYLENE PRODUCTION METHOD | DAIKIN INDUSTRIES, LTD. (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-3666802-A1 | METHOD FOR PRODUCING PURIFIED POLYTETRAFLUOROETHYLENE AQUEOUS DISPERSION LIQUID, METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE POWDER, METHOD FOR PRODUCING POLYTETRAFLUOROETHYLENE MOLDED BODY, AND COMPOSITION | Daikin Industries, Ltd. (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-7488832-B2 | e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome | WYETH (US) | 2009-02-10 | — | — | US | disclosed |
| US-20080287424-A1 | AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS | WYETH (US) | 2008-11-20 | — | — | US | disclosed |
| US-20060183790-A1 | Azolylacylguanidines as beta-secretase inhibitors | WYETH (US) | 2006-08-17 | — | — | US | disclosed |
| JP-H09194471-A | 2,5-DIARYLFURAN DERIVATIVE AND ITS PRODUCTION | MITSUBISHI CHEM CORP | 1997-07-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287424-A1 | AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS | BACE1, BACE2, APP | KMT2A 634/4885MAPT 30/4885CES2 2049/4885 |
| US-20060183790-A1 | Azolylacylguanidines as beta-secretase inhibitors | BACE1, BACE2, APP | KMT2A 634/4885MAPT 30/4885CES2 2049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.